Aurora Cannabis (ACB) is pleased to announce that Simona King, a former executive of Bristol Myers-Squibb (BMY), has been appointed as CFO of the company, effective February 21. King brings over 25 years of progressive finance leadership experience, with deep business knowledge and proven success with global and emerging organizations. She served nearly 20 years with Bristol Myers-Squibb, where she held increasingly senior finance roles and enabled the company’s growth strategy. Glen Ibbott, current CFO, will be stepping down from his full-time role effective Feb. 20 to pursue new opportunities. He will remain in an advisory role over the next few months to ensure a smooth transition of responsibilities to Simona.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on ACB:
- Aurora Cannabis trading halted, news pending
- Rising High: Exclusive talk with cannabis market research firm BDSA
- PayPal downgraded, United Airlines upgraded: Wall Street’s top analyst calls
- Aurora Cannabis upgraded to Buy on valuation at Canaccord
- Aurora Cannabis upgraded to Buy from Hold at Canaccord
Questions or Comments about the article? Write to editor@tipranks.com